On Saturday, University of Central Oklahoma senior Meagan McLain will walk across the stage at commencement. The 24-year-old will shake hands, receive her diploma and toss her cap in the air. And with her newly minted degree in marketing, she’ll think of all that lies ahead for her: a career, a family, a life. But […]
Charles
OMRF to host international symposium on heart disease
Top cardiovascular researchers from around the world will converge in Oklahoma City this week to discuss advances and emerging therapies for thrombosis, a primary cause of heart disease. The Oklahoma Medical Research Foundation, home to some of the world’s experts in this field, will play host to the Thrombosis Symposium on May 29. The event […]
Teaching an old drug new tricks
When Dr. Charles Esmon began studying activated protein C in the 1970s, he never imagined his work would lead to a pair of life-saving drugs. “Back then, we didn’t even know what activated protein C did in the body,” said the Oklahoma Medical Research Foundation scientist. “Our goal was to figure it out.” Figure it […]
Sepsis survivor thanks OMRF scientists who saved her
Rayna DuBose came to say thank you. And thank you and thank you and thank you. “OMRF, the scientists and doctors—it’s good to meet the people who helped save me,” she said. “I just wanted to say thank you. I can’t say it enough.” DuBose, a 24-year-old Virginian, spoke Tuesday to more than 100 Oklahoma […]
FDA approves Protein C deficiency drug with OMRF roots
The U.S. Food and Drug Administration (FDA) has approved a new drug that has its origins at the Oklahoma Medical Research Foundation as the first biologic treatment for patients with a rare genetic defect that can cause a potentially life-threatening clotting disorder. The drug is a treatment for patients with complications related to severe congenital […]
OMRF to name new board members, chairs
At its annual honors and awards banquet this evening, the Oklahoma Medical Research Foundation will name a pair of scientists as endowed chairs and add two new members to its board of directors. Xiao-Hong Sun, Ph.D., will be installed as the Eli Lilly Distinguished Chair in Biomedical Research, while Gary Gorbsky, Ph.D., will become the […]
